PUBLIC COMPANY
save$FDMT4D Molecular Therapeutics, Inc.
$FDMTEmeryville, CA, USupdated 21d ago
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- phase34D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- phase24D-710 in Adult Patients With Cystic Fibrosis
- phase24D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- phase24D-150 in Patients With Diabetic Macular Edema
- phase1Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
- phase24D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
- phase24D-310 in Adults With Fabry Disease and Cardiac Involvement
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Mar 25, 26grantSimms Christopher Paul · See Remarks219,000 sh
- Mar 25, 26grantKirn David · Chief Executive Officer750,000 sh
- Mar 25, 26grantBizily Scott · Chief Legal Officer217,000 sh
- Mar 20, 26option exerciseGupta Ashoo · VP, Finance and Controller221 sh
- Mar 20, 26option exerciseGupta Ashoo · VP, Finance and Controller865 sh
- Mar 20, 26option exerciseGupta Ashoo · VP, Finance and Controller865 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that